{
    "nct_id": "NCT06229392",
    "official_title": "A Phase I Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer",
    "inclusion_criteria": "* ECOG 0-2\n* Patients must be planning to receive standard of car e neoadjuvant chemotherapy as defined by the most recent version of NCCN guidelines (www.nccn.org)\n* Patients must have histologically or cytologically confirmed invasive breast cancer that is either triple-negative or HER2+ (regardless of hormone receptor status)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients with any uncontrolled intercurrent illness.\n* Patients who have any underlying medical condition for which, in the investigator's opinion, participation would not be in the best interest of the participant\n* History of egg allergy\n* Patients currently on anticoagulant therapy, corticosteroids, or immunosuppressive agents\n* History of allergic reactions attributed to compounds of similar chemical or biologic composition to the seasonal flu vaccine.\n* History of Guillain-Barr√© syndrome",
    "miscellaneous_criteria": ""
}